| Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed) National Institutes of Health · PAR-25-197 | Public universities | — | May 28, 2027 |
| Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) National Institutes of Health · PAR-25-210 | States, Counties, Cities & townships +12 | — | Jun 2, 2027 |
| Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) National Institutes of Health · PAR-25-211 | States, Counties, Cities & townships +12 | — | Jun 2, 2027 |
| NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) National Institutes of Health · PAR-25-416 | States, Counties, Cities & townships +12 | — | Jun 14, 2027 |
| BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional) National Institutes of Health · RFA-MH-26-140 | States, Counties, Cities & townships +12 | — | Jun 15, 2027 |
| BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) National Institutes of Health · RFA-MH-26-120 | States, Counties, Cities & townships +12 | — | Jun 15, 2027 |
| Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) National Institutes of Health · RFA-DC-26-001 | States, Counties, Cities & townships +12 | $1.0M | Jun 17, 2027 |
| Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) National Institutes of Health · RFA-TR-25-002 | States, Counties, Cities & townships +12 | — | Jul 2, 2027 |
| NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) National Institutes of Health · PAR-24-209 | States, Counties, Cities & townships +12 | — | Jul 12, 2027 |
| NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) National Institutes of Health · PAR-24-211 | States, Counties, Cities & townships +12 | — | Jul 12, 2027 |
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) National Institutes of Health · PA-24-254 | States, Counties, Cities & townships +12 | — | Jul 12, 2027 |
| Successor-in-Interest (Type 6 Parent Clinical Trial Optional) National Institutes of Health · PA-24-253 | States, Counties, Cities & townships +12 | — | Jul 17, 2027 |
| Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) National Institutes of Health · PAR-25-101 | States, Counties, Cities & townships +12 | $150K | Aug 11, 2027 |
| Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) National Institutes of Health · PAR-24-293 | States, Counties, Cities & townships +12 | — | Aug 18, 2027 |
| Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) National Institutes of Health · PAR-24-330 | States, Counties, Cities & townships +12 | — | Sep 7, 2027 |
| Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-112 | States, Counties, Cities & townships +12 | — | Sep 7, 2027 |
| Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-113 | States, Counties, Cities & townships +12 | — | Sep 7, 2027 |
| Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) National Institutes of Health · PAR-24-325 | States, Counties, Cities & townships +12 | — | Sep 7, 2027 |
| NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) National Institutes of Health · PA-25-080 | States, Counties, Cities & townships +12 | — | Sep 7, 2027 |
| Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-325 | States, Counties, Cities & townships +12 | — | Sep 10, 2027 |
| NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed) National Institutes of Health · PAR-24-301 | States, Counties, Cities & townships +12 | — | Sep 25, 2027 |
| Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-195 | Public universities | — | Sep 28, 2027 |
| Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-194 | Public universities | — | Sep 28, 2027 |
| Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional) National Institutes of Health · PAR-25-196 | Public universities | — | Sep 28, 2027 |
| Clinical and Translational Science Award (UM1 Clinical Trial Optional) National Institutes of Health · PAR-24-272 | States, Counties, Cities & townships +12 | — | Sep 28, 2027 |
| Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-020 | States, Counties, Cities & townships +12 | — | Sep 29, 2027 |
| Home Study and Post-Release Services for Unaccompanied Alien Children Administration for Children and Families - ORR · HHS-2026-ACF-ORR-ZU-0019 | States, Counties, Cities & townships +12 | $555.0M | Oct 1, 2027 |
| BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed) National Institutes of Health · RFA-NS-27-015 | States, Counties, Cities & townships +12 | $10.0M | Oct 4, 2027 |
| Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional) National Institutes of Health · PAR-25-327 | States, Counties, Cities & townships +12 | — | Oct 8, 2027 |
| Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-248 | States, Counties, Cities & townships +12 | — | Oct 8, 2027 |
| NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional) National Institutes of Health · RFA-DC-25-002 | States, Counties, Cities & townships +12 | $500K | Oct 12, 2027 |
| NCI Pathway to Independence Award (K99/R00 Clinical Trial Required) National Institutes of Health · PAR-25-313 | States, Counties, Cities & townships +12 | — | Oct 14, 2027 |
| NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-135 | States, Counties, Cities & townships +12 | — | Oct 14, 2027 |
| Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required) National Institutes of Health · PAR-25-285 | States, Counties, Cities & townships +12 | — | Oct 15, 2027 |
| Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) National Institutes of Health · PAR-25-184 | States, Counties, Cities & townships +12 | — | Oct 15, 2027 |
| Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) National Institutes of Health · PAR-25-181 | States, Counties, Cities & townships +12 | — | Oct 15, 2027 |
| Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) National Institutes of Health · PAR-25-182 | States, Counties, Cities & townships +12 | — | Oct 15, 2027 |
| First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required) National Institutes of Health · PAR-25-180 | States, Counties, Cities & townships +12 | — | Oct 15, 2027 |
| Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required) National Institutes of Health · PAR-25-183 | States, Counties, Cities & townships +12 | — | Oct 15, 2027 |
| Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required) National Institutes of Health · PAR-25-178 | States, Counties, Cities & townships +12 | — | Oct 15, 2027 |
| Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) National Institutes of Health · PAR-25-179 | States, Counties, Cities & townships +12 | — | Oct 15, 2027 |
| Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required) National Institutes of Health · PAR-25-177 | States, Counties, Cities & townships +12 | — | Oct 15, 2027 |
| NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional) National Institutes of Health · PAR-25-120 | States, Counties, Cities & townships +12 | — | Oct 15, 2027 |
| NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-357 | States, Counties, Cities & townships +12 | — | Oct 16, 2027 |
| NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required) National Institutes of Health · PAR-25-343 | States, Counties, Cities & townships +12 | — | Oct 18, 2027 |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) National Institutes of Health · RFA-CA-27-019 | States, Counties, Cities & townships +12 | $2.4M | Oct 19, 2027 |
| Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) National Institutes of Health · PAR-25-296 | Public universities | $650K | Oct 19, 2027 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-225 | States, Counties, Cities & townships +12 | — | Oct 20, 2027 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-060 | States, Counties, Cities & townships +12 | $750K | Oct 20, 2027 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-059 | States, Counties, Cities & townships +12 | $750K | Oct 20, 2027 |